TNF-α enhances phenotypic and functional maturation of human epidermal Langerhans cells and induces IL-12 p40 and IP-10/CXCL-10 production

被引:57
作者
Berthier-Vergnes, O
Bermond, F
Flacher, V
Massacrier, C
Schmitt, D
Péguet-Navarro, J
机构
[1] Univ Lyon 1, Hop Edouard Herriot, EA 37 32, F-69437 Lyon, France
[2] Schering Plough Corp, Inst Res, Lab Immunol Res, Dardilly, France
关键词
human Langerhans cells; cytokines; maturation;
D O I
10.1016/j.febslet.2005.04.087
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dendritic cells (DC) play a central role in immunity/ tolerance decision, depending on their activation/maturation state. TNF-alpha is largely produced in the skin under inflammatory conditions. However, it still remains to be defined how TNF-alpha( modulates the activation status of human LC, the most specialized DC controlling skin immunity. Here, we reported that fresh immature LC, highly purified from healthy human skin and exposed for two days to TNF-a under serum-free conditions, expressed up-regulated level of co-stimulatory molecules (CD40, CD54, CD86), maturation markers (CD83, DC-LAMP), CCR7 lymph node homing receptor, and down-regulated Langerin level, in a dose-dependent manner. This mature phenotype is closely associated with enhanced LC allostimulatory capacity. Furthermore, TNF-alpha( significantly increased the number of viable LC and decreased their spontaneous apoptosis. More importantly, TNF-alpha induced LC to produce both IFN-gamma-inducible-protein IP-10/CXCL10, a Th1-attracting chemokine and IL-12 p40. Bioactive IL-12 p70 was never detected, even after additional CD40 stimulus. The results implicate LC as an effective target through which TNF-alpha may up- or down-regulate the inflammatory skin reactions. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:3660 / 3668
页数:9
相关论文
共 36 条
  • [1] IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines
    Albanesi, C
    Scarponi, C
    Sebastiani, S
    Cavani, A
    Federici, M
    De Pità, O
    Puddu, P
    Girolomoni, G
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (03) : 1395 - 1402
  • [2] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [3] Regulatory activity of autocrine IL-10 on dendritic cell functions
    Corinti, S
    Albanesi, C
    la Sala, A
    Pastore, S
    Girolomoni, G
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (07) : 4312 - 4318
  • [4] IL-10 induces CCR6 expression during Langerhans cell development while IL-4 and IFN-γ suppress it
    Dieu-Nosjean, MC
    Massacrier, C
    Vanbervliet, B
    Fridman, WH
    Caux, C
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (10) : 5594 - 5602
  • [5] IFN-γ-Inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking
    Dufour, JH
    Dziejman, M
    Liu, MT
    Leung, JH
    Lane, TE
    Luster, AD
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (07) : 3195 - 3204
  • [6] Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4
    Ebner, S
    Ratzinger, G
    Krösbacher, B
    Schmuth, M
    Weiss, A
    Reider, D
    Kroczek, RA
    Herold, M
    Heufler, C
    Fritsch, P
    Romani, N
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (01) : 633 - 641
  • [7] Differential production of Th1- and Th2-type chemokines by mouse Langerhans cells and splenic dendritic cells
    Fujita, H
    Asahina, A
    Sugaya, M
    Nakamura, K
    Gao, P
    Fujiwara, H
    Tamaki, K
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (02) : 343 - 350
  • [8] Geissmann F, 1999, J IMMUNOL, V162, P4567
  • [9] DETECTION OF A GAMMA-INTERFERON-INDUCED PROTEIN IP-10 IN PSORIATIC PLAQUES
    GOTTLIEB, AB
    LUSTER, AD
    POSNETT, DN
    CARTER, DM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (03) : 941 - 948
  • [10] T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal
    Kalinski, P
    Hilkens, CMU
    Wierenga, EA
    Kapsenberg, ML
    [J]. IMMUNOLOGY TODAY, 1999, 20 (12): : 561 - 567